Related Experiment Video
Updated: Aug 11, 2026

Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance
Published on: July 28, 2023
Antimicrobial resistance in Helicobacter pylori isolates from children
S Rerksuppaphol1, W Hardikar, P D Midolo
1Department of Paediatric Gastroenterology and Clinical Nutrition, Royal Children's Hospital, Austin Hospital, Melbourne, Victoria, Australia.
Insights
Helicobacter pylori resistance to metronidazole is high in children, while clarithromycin resistance is moderate. Amoxycillin and tetracycline resistance were not observed, suggesting treatment modifications may be needed.
Area of Science:
- Pediatric infectious diseases
- Microbiology
- Antimicrobial resistance
Background:
- Helicobacter pylori infection is common in children.
- Treatment of H. pylori relies on effective antimicrobial agents.
- Understanding antimicrobial resistance patterns is crucial for effective treatment.
Purpose of the Study:
- To determine the antimicrobial resistance rates of H. pylori in pediatric patients.
- To assess resistance to metronidazole, clarithromycin, amoxycillin, and tetracycline.
Main Methods:
- Prospective collection of H. pylori isolates from children undergoing gastroscopy (July 1997-January 2000).
- Susceptibility testing using E-test for four antimicrobial agents.
- Retrospective collection of demographic, clinical, and treatment data.
Main Results:
- High resistance rate to metronidazole (43.5%) and moderate resistance to clarithromycin (8.7%).
- No resistance observed for amoxycillin or tetracycline.
- No significant differences in patient characteristics or treatment outcomes between susceptible and resistant groups.
Conclusions:
- Pediatric H. pylori resistance patterns to metronidazole and clarithromycin mirror adult data.
- High resistance rates necessitate consideration of antimicrobial susceptibility testing for H. pylori management in children.
- Treatment guidelines may require updates to ensure eradication efficacy.
Objective:
To determine the resistance rate to four antimicrobial agents commonly used in the treatment of Helicobacter pylori infection in children.
Methods:
Between July 1997 and January 2000, all H. pylori isolates from children undergoing gastroscopy were prospectively collected and subcultured to yield the susceptibility to four antimicrobial agents by E-test. In all, 23 isolates were tested. Demographic data, presenting symptoms, treatment regimen and clinical improvement after treatment were collected retrospectively.
Results:
The resistance rate of H. pylori to metronidazole and clarithromycin were 43.5% and 8.7%, respectively. No H. pylori strains were resistant to amoxycillin or tetracycline. There were no statistically significant differences in age, sex, ethnicity, presenting symptoms or clinical improvement after treatment between antimicrobial-susceptible and antimicrobial-resistant groups.
Conclusions:
The frequent resistance of H. pylori to metronidazole and moderate resistance to clarithromycin in children are comparable with local adult data. The incidence of resistance tended to be higher in patients of non-European ethnicity, but this was not statistically significant. Given that the primary goal of therapy is eradication, and that local resistance rates are high, recommendations for H. pylori management may need to be modified to include sensitivity testing and/or determination of eradication in all patients.
More Related Videos
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
04:56Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
Published on: May 16, 2025
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Development of Antibiotic Resistance
Peptic Ulcer
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Gastritis II: Pathophysiology